Rhythm Pharmaceuticals, Inc. RYTM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 89.4%-0.3pp | 89.7%+0.3pp | 89.4%+0.2pp | 89.2%-0.4pp | 89.6%-0.1pp | |
| Operating margin | -90.9%+10.3pp | -101.2%+5.6pp | -106.8%+6.7pp | -113.5%+12.6pp | -126.1%+77.9pp | |
| Net margin | -93.3%+10.2pp | -103.6%+6.7pp | -110.3%+6.8pp | -117.1%+6.1pp | -123.3%+77.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×+0.1× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×+0.1× | |
| Liquidity | ||||||
| Current ratio | 4.2×-0.2× | 4.4×-0.3× | 4.7×+2.0× | 2.8×-0.5× | 3.3×+0.1× | |
| Per Share | ||||||
| Book value per share | $1.81-15.5% | $2.14-4.7% | $2.25+1,301% | -$0.19-162% | $0.30-15.6% | |
| Valuation | ||||||
| Market capitalization | $5.94B-16.9% | $7.14B+6.5% | $6.71B+65.6% | $4.05B+20.9% | $3.35B-2.7% | |
| Price / sales | 27.3×-10.3× | 37.6×-0.8× | 38.5×+12.6× | 25.9×+1.4× | 24.5×-2.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rhythm Pharmaceuticals, Inc.'s profit margins?
- Rhythm Pharmaceuticals, Inc. (RYTM) runs a 89.4% gross margin and a -90.9% operating margin, with a -93.3% net margin.
- Where do Rhythm Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Rhythm Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
